Pump spray for sublingual application in 20 mL pump spray bottles. The placebo contains all excipients of AP707 without the addition of cannabis sativa (active ingredient). The appearance of the preparation is a brown-beige with a characteristic sweet and slightly fruity odor.
Sponsors
Cannaxan GmbH, Apurano Pharmaceuticals GmbH
Conditions
Chronic Pain due to traumatic or post-operative peripheral NeuropathyChronic back painChronic pain due to central Neuropathy of any GenesisChronic pain due to diabetic polyneuropathy
Phase 3
Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain
SuspendedCTIS2022-502151-54-00
Start: 2023-11-02Target: 558Updated: 2024-11-22
Efficacy and Tolerability of AP707 in Patients with chronic pain due to central Neuropathy of any Genesis
SuspendedCTIS2022-500899-66-00
Start: 2023-11-02Target: 558Updated: 2024-06-28
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to traumatic or post-operative peripheral Neuropathy
SuspendedCTIS2022-500898-13-00
Start: 2023-11-02Target: 558Updated: 2024-07-01
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy
SuspendedCTIS2022-500897-32-00
Start: 2023-11-02Target: 558Updated: 2024-07-29